返回
Collaborative Accelerators for Streamlining MapReduce on Scale-up Machines With Incremental Data Aggregation
DOI:10.1109/TC.2020.3004169.png)
摘要
En 中文
The MapReduce programming paradigm has been increasingly adopted to implement data-intensive applications processing both small and large scale datasets. As most jobs in data centers have a data footprint in the order of gigabytes, emerging high-end scale-up machines are capable of running most data center processing tasks, thus significantly improving power and server density. However, this approach provides limited performance and energy efficiency because of inefficient utilization of the memory subsystem and serial execution within the MapReduce programming model. Recent work has proposed a distributed hardware acceleration architecture, called CASM, which augments each core in a scale-up machine with a lightweight compute engine. The CASM's network of accelerators operates concurrently with the cores in executing MapReduce stages and reduces significantly traffic to/from storage. In this article, we study the benefits and applicability of CASM, by offering an extensive analysis of design parameters and of its scalable performance on a wide range of applications, and exploring its applicability to incremental data aggregation tasks. Our experimental evaluation indicates that CASM reduces off-chip traffic by four times on average over a chip multiprocessor solution, while scaling well with the number of cores in the system, and it is highly effective in providing incremental results that approximate final outcomes.
Keyword:
Online MapReduce
domain-specific architecture
scale-up machine
collaborative accelerators
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
3.8
论文数:
5.4K
被引数:
9.8K
机构
引用论文
Clinical, immunological and microbial gingival profile of juvenile systemic lupus erythematosus patients
Lupus
IF0
Influence Of GST Gene Polymorphisms On Busulfan Pharmacokinetics and Outcome Of Hematopoietic Stem Cell Transplantation In Thalassemia Pediatric Patients
Blood
IF0

